Vanberra Signal

Delfi Diagnostics

Curated by Signal

Provider of DNA sequencing for cancer detection

Overview

Provider of DNA sequencing for cancer detection. The company's platform uses artificial intelligence and whole genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients with cancer.

Key facts

Founded
2019

Business model

Contact

Open roles

34 roles
  • Facilities Manager (Contract)

    Palo Alto, CA · On-site · Volunteer

  • Clinical Laboratory Scientist - PM Shift (Contract)

    Palo Alto, CA · On-site · Volunteer

  • Senior Research Associate, Assay Development (Contract)

    Palo Alto, CA · On-site · Volunteer

+ 31 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Non-invasive algorithm-based diagnostics

    Life Sciences TechnologyOrlando, United States
  • Provider of a cloud-based bioinformatics platform for biotech research

    Life Sciences TechnologySan Francisco, United States
  • Provider of cold chain logistics for the life sciences industry

    Life Sciences TechnologyIrvine, United States

About Delfi Diagnostics

What does Delfi Diagnostics do?

Provider of DNA sequencing for cancer detection.

Where is Delfi Diagnostics headquartered?

Delfi Diagnostics is headquartered in Baltimore, United States.

When was Delfi Diagnostics founded?

Delfi Diagnostics was founded in 2019.

Which sector is Delfi Diagnostics in?

Delfi Diagnostics operates in Life Sciences Technology.

Who are Delfi Diagnostics's competitors?

Companies similar to Delfi Diagnostics include Fibronostics, Benchling, and Cryoport.

Is Delfi Diagnostics hiring?

Yes. Delfi Diagnostics has 34 open roles listed on Vanberra Signal.